Herpes simplex keratitis: challenges in diagnosis and clinical management

Herpes simplex virus is responsible for numerous ocular diseases, the most common of which is herpetic stromal keratitis. This is a recurrent infection of the cornea that typically begins with a subclinical infection of the cornea that establishes a latent infection of sensory ganglia, most often the trigeminal ganglia. Recurring infections occur when the virus is reactivated from latency and travels back to the cornea, where it restimulates an inflammatory response. This inflammatory response can lead to decreased corneal sensation, scarring, and blindness. The diagnosis of these lesions as the result of a recurrent herpes simplex virus infection can at times be problematic. Currently, herpetic stromal keratitis is diagnosed by its clinical presentation on the slit-lamp examination, but the literature does not always support the accuracy of these clinical findings. Other diagnostic tests such as polymerase chain reaction assay, enzyme-linked immunosorbent assay, immunofluorescent antibody, and viral cultures have provided more definitive diagnosis, but also have some limitations. That said, accurate diagnosis is necessary for proper treatment, in order to prevent serious consequences. Current treatment reduces the severity of lesions and controls further viral spread, but does not provide a cure.

[1]  D. Kimberlin,et al.  Neonatal herpes simplex virus infections. , 2013, Pediatric clinics of North America.

[2]  M. Moschos,et al.  Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents , 2016, Clinical & experimental ophthalmology.

[3]  E. Takamura,et al.  A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation , 2016, Japanese Journal of Ophthalmology.

[4]  A. Mitra,et al.  Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective. , 2013, Recent patents on anti-infective drug discovery.

[5]  Asim V. Farooq,et al.  Herpes simplex epithelial and stromal keratitis: an epidemiologic update. , 2012, Survey of ophthalmology.

[6]  H. Kaufman,et al.  Ganciclovir Ophthalmic Gel 0.15%: Safety and Efficacy of a New Treatment for Herpes Simplex Keratitis , 2012, Current eye research.

[7]  Jamie D. Croxtall Ganciclovir Ophthalmic Gel 0.15% , 2011, Drugs.

[8]  James M. Hill,et al.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? , 2011, Future microbiology.

[9]  Jonathan E. Moore,et al.  A Comparison of the Clinical and Molecular Diagnosis of Herpes Simplex Keratitis , 2011 .

[10]  G. Boivin,et al.  Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management , 2010, Antimicrobial Agents and Chemotherapy.

[11]  R. Zell,et al.  Testing of herpes simplex virus for resistance to antiviral drugs. , 2010, Virulence.

[12]  Pedram Hamrah,et al.  Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. , 2010, Ophthalmology.

[13]  N. Nayak,et al.  Evaluation of tear samples for Herpes Simplex Virus 1 (HSV) detection in suspected cases of viral keratitis using PCR assay and conventional laboratory diagnostic tools , 2010, British Journal of Ophthalmology.

[14]  M. C. Acosta,et al.  Selective changes in human corneal sensation associated with herpes simplex virus keratitis. , 2010, Investigative ophthalmology & visual science.

[15]  K. Wilhelmus Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. , 2010, The Cochrane database of systematic reviews.

[16]  P. Charukamnoetkanok,et al.  Management of herpes simplex virus stromal keratitis: an evidence-based review. , 2009, Survey of ophthalmology.

[17]  R. Schinazi,et al.  Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. , 2008, Cell host & microbe.

[18]  P. Rama,et al.  Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. , 2007, American journal of ophthalmology.

[19]  F. Marangon,et al.  Laboratory results in ocular viral diseases: implications in clinical-laboratory correlation. , 2007, Arquivos brasileiros de oftalmologia.

[20]  L. Laroche,et al.  Effects of topical anaesthetics and fluorescein on the real-time PCR used for the diagnosis of Herpesviruses and Acanthamoeba keratitis , 2006, British Journal of Ophthalmology.

[21]  S. Kaye,et al.  Herpes simplex keratitis. , 1996, Journal of medical microbiology.

[22]  D. Pavan-Langston,et al.  Herpes Simplex Ocular Inflammatory Disease , 2006, International ophthalmology clinics.

[23]  T. Margolis,et al.  Rose bengal and lissamine green inhibit detection of herpes simplex virus by PCR. , 2006, American journal of ophthalmology.

[24]  A. A. El-Aal,et al.  Evaluation of Herpes Simplex Detection in Corneal Scrapings by Three Molecular Methods , 2006, Current Microbiology.

[25]  J. Lavail,et al.  Genetic and Molecular In Vivo Analysis of Herpes Simplex Virus Assembly in Murine Visual System Neurons , 2005, Journal of Virology.

[26]  E. Miserocchi,et al.  Comparison of the Efficacy of Valacyclovir vs Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease , 2005 .

[27]  R. D. Stulting,et al.  Corneal Thickness Changes During Herpes Simplex Virus Disciform Keratitis , 2004, Cornea.

[28]  E. Holland,et al.  Bilateral herpetic keratoconjunctivitis. , 2003, Ophthalmology.

[29]  C. Begley,et al.  Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. , 2003, Archives of ophthalmology.

[30]  D. Thouvenot,et al.  Herpes simplex virus resistance to antiviral drugs. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[31]  W. Snowden,et al.  Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. , 2002, Journal of Infectious Diseases.

[32]  T. Das,et al.  Reliability of nested polymerase chain reaction in the diagnosis of bacterial endophthalmitis. , 2002, American journal of ophthalmology.

[33]  S. Soong,et al.  Natural history of neonatal herpes simplex virus infections in the acyclovir era. , 2001, Pediatrics.

[34]  Predictors of Recurrent Herpes Simplex Virus Keratitis , 2001 .

[35]  T. Liesegang Herpes Simplex Virus Epidemiology and Ocular Importance , 2001, Cornea.

[36]  R. D. Stulting,et al.  Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group. , 2000, Archives of ophthalmology.

[37]  W. Leong,et al.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. , 1999, The New England journal of medicine.

[38]  A. Anand,et al.  Detection of herpes simplex virus (HSV) genome using polymerase chain reaction (PCR) in clinical samples comparison of PCR with standard laboratory methods for the detection of HSV. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[39]  N. Koizumi,et al.  Detection of herpes simplex virus DNA in atypical epithelial keratitis using polymerase chain reaction , 1999, The British journal of ophthalmology.

[40]  E. Holland,et al.  Classification of herpes simplex virus keratitis. , 1999, Cornea.

[41]  H. Shiota,et al.  Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: Analysis of clinical isolates from herpetic keratitis patients and laboratory strains , 1998, Journal of medical virology.

[42]  A. Rübben,et al.  Routine detection of herpes simplex virus and varicella zoster virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex , 1997, The British journal of dermatology.

[43]  S. Resnikoff,et al.  Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. , 1997, Cornea.

[44]  J. Zeh,et al.  Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. , 1997, The Journal of clinical investigation.

[45]  R. Hendricks,et al.  Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. , 1997, Journal of immunology.

[46]  C. Perry,et al.  Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. , 1996, Drugs.

[47]  R. Hendricks,et al.  Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus- infected mouse corneas , 1996, The Journal of experimental medicine.

[48]  E. Dreyer,et al.  Herpesvirus Infections of the Anterior Segment , 1996, International ophthalmology clinics.

[49]  W. Hauck,et al.  Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis , 1994 .

[50]  T. Olsen,et al.  Linear endotheliitis. , 1994, American journal of ophthalmology.

[51]  D. Faulds,et al.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. , 1994, Drugs.

[52]  P. Kinchington,et al.  A comparison of enzyme immunoassay and polymerase chain reaction with the clinical examination for diagnosing ocular herpetic disease. , 1993, Ophthalmology.

[53]  B. Roizman,et al.  Amplification by host cell factors of a sequence contained within the herpes simplex virus 1 genome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[54]  L. Melton,et al.  Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. , 1989, Archives of ophthalmology.

[55]  S. Darougar,et al.  Epidemiological and clinical features of primary herpes simplex virus ocular infection. , 1985, The British journal of ophthalmology.

[56]  H. E. Kaufman,et al.  Herpes simplex keratitis. , 1983, Ophthalmology.

[57]  P. de Miranda,et al.  Pharmacokinetics of acyclovir after intravenous and oral administration. , 1983, The Journal of antimicrobial chemotherapy.

[58]  T. H. Pettit,et al.  Viral antigens in the immune ring of Herpes simplex stromal keratitis. , 1980, Archives of ophthalmology.

[59]  R. O. Schultz,et al.  Experimental herpes simplex keratitis. Early alterations of corneal epithelium and stroma. , 1970, Archives of ophthalmology.

[60]  H. Edelhauser,et al.  Experimental herpes simplex keratitis. Corneal hydration, electrolyte content and structural changes. , 1969, American journal of ophthalmology.